Jennifer Hammaker has watched biotech company respEQ Inc. grow from an experiment in a Johns Hopkins lab to a fledgling startup now looking for investors.
RespEQ is a prime example of what Hammaker, who leads the Maryland Innovation Initiative, hopes the state's research commercialization program will produce more of in the future.